Buy & Sell ACADIA Pharmaceuticals Inc. (ACAD) – ACADIA Pharmaceuticals Inc. Price Today
Aura AI Summary
Key Stats
- $3.74BMarket Cap
- HealthSector
- -22.23%3M Drawdown
- $2.98BEnterprise Value
- -Dividend Yield
- 73 daysTypical Hold Time
ACADIA Pharmaceuticals Inc. (ACAD) is currently valued at a market capitalization of $3.74B, with an enterprise value of $2.98B. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $14.43 and a high of $28.06, highlighting its annual price range. Over the past three months, ACADIA Pharmaceuticals Inc. has recorded a drawdown of -22.23%, reflecting recent price volatility. On average, investors hold ACADIA Pharmaceuticals Inc. for approximately 73 days, indicating typical investor behavior on the platform.
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
